title: How parents hear about human papillomavirus vaccine: implications for uptake.
abstract: OBJECTIVE
  To examine correlates of human papillomavirus (HPV) vaccine awareness and information sources in a state requiring schools to inform parents about HPV vaccine.
  
  
  METHODS
  Telephone survey of a North Carolina population-based sample of 696 parents of females aged 10-17 years about HPV vaccine awareness and information sources (daughters' schools, healthcare provider, drug company advertisements, news stories) was conducted.
  
  
  RESULTS
  Overall, 91% of parents had heard of HPV vaccine. Parents were more likely to be aware if they had household incomes of $50,000 or higher, were women, had non-Hispanic white daughters, or had daughters vaccinated against meningitis. Information sources included drug company advertisements (64%), healthcare providers (50%), news stories (50%), and schools (9%). Only parents who heard from their children's healthcare providers were more likely to initiate HPV vaccine for their daughters.
  
  
  CONCLUSIONS
  Parents had rarely heard of the vaccine through schools. The only source associated with vaccine initiation was hearing from a healthcare provider.
authors: School of Journalism and Mass Communication, University of North Carolina, Chapel Hill, North Carolina 27599-3365, USA. JoanCates@unc.edu
authors: Joan R
authors: JR
authors: Cates
authors: Autumn
authors: A
authors: Shafer
authors: Francesca D
authors: FD
authors: Carpentier
authors: Paul L
authors: PL
authors: Reiter
authors: Noel T
authors: NT
authors: Brewer
authors: Annie-Laurie
authors: AL
authors: McRee
authors: Jennifer S
authors: JS
authors: Smith
mesh_terms: D000293:Adolescent; D001364:Awareness; D002648:Child; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D033181:Information Dissemination / Q000379:methods*; D007407:Interviews as Topic; D009657:North Carolina; D053918:Papillomavirus Vaccines; D010290:Parents; D012959:Socioeconomic Factors
chemical_list: D053918:Papillomavirus Vaccines